Cellebrite DI Ltd.
CLBT
$19.85
$0.010.05%
NASDAQ
| 12/31/2023 | 12/31/2023 | 09/30/2023 | |||
|---|---|---|---|---|---|
| Net Income | -325.34% | -325.34% | 120.09% | ||
| Total Depreciation and Amortization | 9.87% | 30.71% | -7.36% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 136.82% | 133.41% | -64.21% | ||
| Change in Net Operating Assets | 272.40% | 272.40% | 0.88% | ||
| Cash from Operations | 50.21% | 50.21% | 76.03% | ||
| Capital Expenditure | -108.87% | -108.87% | -31.15% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 155.24% | 155.24% | 1.05% | ||
| Cash from Investing | 129.01% | 129.01% | -1.42% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -48.62% | -48.62% | 54.97% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -48.62% | -48.62% | 54.97% | ||
| Foreign Exchange rate Adjustments | 274.21% | 274.21% | -7,742.86% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 97.45% | 97.45% | 130.39% | ||